Suchergebnisse - "Chakravarty, Soumya D"

PubPharm (129)

1

The Sjögren's Working Group : The 2023 OMERACT meeting and provisional domain generation

enthalten in: Seminars in arthritis and rheumatism | 2024

von Gordon, R. | Nguyen, Y. | Foulquier, N. | +47

2

Improvements in Patient-Reported Outcomes Through Six Months of Guselkumab Treatment in Patients With Active Psoriatic Arthritis : Real-World Data From the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry

enthalten in: ACR open rheumatology | 2024

von Mease, P. | Ogdie, A. | Tesser, J. | +9

3

Continuous improvement through differential trajectories of individual minimal disease activity criteria with guselkumab in active psoriatic arthritis : post hoc analysis of a phase 3, randomized, double-blind, placebo-controlled study

enthalten in: BMC rheumatology | 2024

von Coates, L. | Rahman, P. | Mease, P. | +7

4

Continuous improvement through differential trajectories of individual minimal disease activity criteria with guselkumab in active psoriatic arthritis: post hoc analysis of a phase 3, randomized, double-blind, placebo-controlled study

enthalten in: BMC Rheumatology | 2024

von Coates, L. | Rahman, P. | Mease, P. | +7

5

Modulation of Interleukin-23 Signaling With Guselkumab in Biologic-Naive Patients Versus Tumor Necrosis Factor Inhibitor-Inadequate Responders With Active Psoriatic Arthritis

enthalten in: Arthritis & rheumatology (Hoboken, N.J.) | 2024

von Siebert, S. | Coates, L. | Schett, G. | +14

6

Long-Term Safety of Guselkumab in Patients with Psoriatic Disease : An Integrated Analysis of Eleven Phase II/III Clinical Studies in Psoriasis and Psoriatic Arthritis

enthalten in: Drug safety | 2024

von Strober, B. | Coates, L. | Lebwohl, M. | +13

7

Earlier clinical response predicts low rates of radiographic progression in biologic-naïve patients with active psoriatic arthritis receiving guselkumab treatment

enthalten in: Clinical rheumatology | 2024

von Mease, P. | Gottlieb, A. | Ogdie, A. | +9

8

A clinical review of structural damage in psoriatic arthritis for dermatologists : From pathogenesis to ongoing controversies

enthalten in: Journal of the American Academy of Dermatology | 2024

von Merola, J. | Chakravarty, S. | Choi, O. | +2

9

Six-Month Persistence and Multi-domain Effectiveness of Guselkumab in Adults with Psoriatic Arthritis : Real-World Data from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry

enthalten in: Rheumatology and therapy | 2023

von Mease, P. | Ogdie, A. | Tesser, J. | +9

10

Efficacy of Guselkumab on Axial-Related Symptoms Through up to 2 Years in Adults with Active Psoriatic Arthritis in the Phase 3, Randomized, Placebo-Controlled DISCOVER-2 Study

enthalten in: Rheumatology and therapy | 2023

von Mease, P. | Gladman, D. | Poddubnyy, D. | +7

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[13]